GAST and gastric neuroendocrine tumor, well differentiated, low or intermediate grade: Incidence of gastric mucosal changes (parietal cell hyperplasia, foveolar hyperplasia, ECL-cell hyperplasia, G-cell hyperplasia); median serum gastrin levels; absence of malignant epithelial changes or gastric NETs